Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy
- 1 March 1995
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 113 (2), 157-166
- https://doi.org/10.1016/0021-9150(94)05439-p
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I)The American Journal of Cardiology, 1993
- Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapyJournal of Internal Medicine, 1993
- Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individualsAtherosclerosis, 1991
- Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotypeAtherosclerosis, 1991
- Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4Atherosclerosis, 1990
- Binding of human apolipoprotein A-IV to human hepatocellular plasma membranesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- A previously reported polymorphic plasma protein of dogs and horses, identified as apolipoprotein A‐IVAnimal Genetics, 1989
- Familial apolipoprotein E deficiency.Journal of Clinical Investigation, 1986
- The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Activation of lecithin : cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasmaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985